Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maxcyte (MXCT) Change in Inventory (2020 - 2025)

Historic Change in Inventory for Maxcyte (MXCT) over the last 6 years, with Q3 2025 value amounting to $107000.0.

  • Maxcyte's Change in Inventory rose 545000.0% to $107000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.2 million, marking a year-over-year decrease of 20179.95%. This contributed to the annual value of -$1.4 million for FY2024, which is 13003.97% down from last year.
  • Maxcyte's Change in Inventory amounted to $107000.0 in Q3 2025, which was up 545000.0% from -$223000.0 recorded in Q2 2025.
  • Maxcyte's 5-year Change in Inventory high stood at $1.7 million for Q1 2023, and its period low was -$664000.0 during Q2 2024.
  • Over the past 5 years, Maxcyte's median Change in Inventory value was $241200.0 (recorded in 2022), while the average stood at $390726.3.
  • As far as peak fluctuations go, Maxcyte's Change in Inventory crashed by 21816.14% in 2024, and later skyrocketed by 545000.0% in 2025.
  • Quarter analysis of 5 years shows Maxcyte's Change in Inventory stood at $1.1 million in 2021, then crashed by 44.62% to $612300.0 in 2022, then fell by 27.16% to $446000.0 in 2023, then plummeted by 218.16% to -$527000.0 in 2024, then surged by 120.3% to $107000.0 in 2025.
  • Its Change in Inventory stands at $107000.0 for Q3 2025, versus -$223000.0 for Q2 2025 and -$531000.0 for Q1 2025.